FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Albuterol Sulfate Inhalation Solution (0.5%, 0.021%, and 0.042%)
Status: Currently in Shortage
»Date first posted: 03/02/2017
»Therapeutic Categories: Pulmonary/Allergy

Nephron Pharmaceuticals Corporation (New 03/02/2017)

Company Contact Information:
800-443-4313

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Albuterol Sulfate Inhalation Solution 0.5%, (2.5 mg/ 0.5 mL) (NDC 0487-9901-30) Regulatory delay

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English